Dynamics of Oligoclonal Hematopoiesis in Severe Aplastic Anemia Patients Undergoing Immunosuppressive Treatment: Longitudinal Somatic Mutation Analysis from the EBMT Race TrialD Kaya, Ghulam Mufti, Nogayhan Seymen et al.|Blood|2024Cited by 2
Eltrombopag Added to Standard Immunosuppressive Treatment Improves Long-Term Outcomes As Front-Line Therapy for Severe Aplastic Anemia: Final 2-Year Analysis of EBMT-Saawp Race StudyAntonio M. Risitano, Régis Peffault de Latour, S. Iacobelli et al.|Blood|2024Cited by 1
Deep immune signature of immune-mediated aplastic anemia patients shows distinct subsets of regulatory T cells associated with response to treatment: Results from the phase 3, randomized EBMT race clinical trialSıla Gerlevik, Ghulam Mufti, Austin Kulasekararaj et al.|Blood|2025Cited by 0